Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2022-03-14 (4 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARDRES (62610), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE JEAN DANNEL : revenue, balance sheet and financial ratios
PHARMACIE JEAN DANNEL is a French company
founded 4 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARDRES (62610),
this company of category PME
shows in 2024 a net income positive of 84 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEAN DANNEL (SIREN 911888808)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
84 039 €
49 475 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE JEAN DANNEL generates positive net income of 84 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 49 k€ -> 84 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
84 039 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 732%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
731.635%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
10.354%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JEAN DANNEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
1885.757
731.635
Financial autonomy
4.252
10.354
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
731.632024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of PHARMACIE JEAN DANNEL (731.63) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
10.35%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE JEAN DANNEL (10.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 178.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
178.718
Liquidity indicators evolution PHARMACIE JEAN DANNEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
163.611
178.718
Interest coverage
None
None
Sector positioning
Liquidity ratio
178.722024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average+10 pts over 2 years
In 2024, the liquidity ratio of PHARMACIE JEAN DANNEL (178.72) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE JEAN DANNEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE JEAN DANNEL is estimated at
1 173 246 €
(range 817 030€ - 1 755 243€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
817k€1173k€1755k€
1 173 246 €Range: 817 030€ - 1 755 243€
NAF 5 année 2024
Valuation method used
Net Income Multiple
84 039 €
×
14.0x
=1 173 247 €
Range: 817 030€ - 1 755 244€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEAN DANNEL with other companies in the same sector:
Frequently asked questions about PHARMACIE JEAN DANNEL
What is the revenue of PHARMACIE JEAN DANNEL ?
The revenue of PHARMACIE JEAN DANNEL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE JEAN DANNEL profitable?
Yes, PHARMACIE JEAN DANNEL generated a net profit of 84 k€ in 2024.
Where is the headquarters of PHARMACIE JEAN DANNEL ?
The headquarters of PHARMACIE JEAN DANNEL is located in ARDRES (62610), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE JEAN DANNEL ?
The tax return of PHARMACIE JEAN DANNEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEAN DANNEL operate?
PHARMACIE JEAN DANNEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart